Seizert Capital Partners, LLC Harvard Bioscience Inc Transaction History

Seizert Capital Partners, LLC

  • $2.16 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021
SELL
$3.0 - $4.5 $102,066 - $153,099
-34,022 Closed
0 $0
Q3 2020

Nov 03, 2020
SELL
$2.75 - $4.2 $47,352 - $72,319
-17,219 Reduced 33.6%
34,022 $102,000
Q2 2020

Aug 06, 2020
SELL
$2.12 - $3.14 $15,798 - $23,399
-7,452 Reduced 12.7%
51,241 $159,000
Q1 2020

May 05, 2020
BUY
$1.42 - $3.29 $83,344 - $193,099
58,693 New
58,693 $130,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Seizert Capital Partners, LLC Portfolio

Follow Seizert Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email